You are here
Autologous cell therapy with SMC modified MAPCs
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43HD046177-01
Agency Tracking Number: HD046177
Amount:
$99,850.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
ATHERSYS, INC.
3201 CARNEGIE AVE
CLEVELAND, OH
44115
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: JOHN Harrington
Phone: (216) 431-9900
Email: JHARRINGTON@ATHERSYS.COM
Phone: (216) 431-9900
Email: JHARRINGTON@ATHERSYS.COM
Business Contact
Name: GIL BOKKELEN
Phone: (216) 431-9900
Email: GILVB@ATHERSYS.COM
Phone: (216) 431-9900
Email: GILVB@ATHERSYS.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The objective of the current proposal is to establish genetic modification of Multipotent Adult Progenitor Cells (MAPCs) with Synthetic Microchromosome vectors (SMCs) as a strategy for application in autologous cell ba
* Information listed above is at the time of submission. *
